BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, February 12, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 9, 1999
View Archived Issues
New antiviral agents from SB for herpesvirus infections
Read More
Avigen granted U.S. patent for TVI gene therapy
Read More
Hughes Institute enters licensing agreement for anticancer drug development
Read More
Discovery's Surfaxin shows positive phase II results in MAS
Read More
IOCM approves Rebif for MS
Read More
Positive results reported for Ergoset in insulin-treated type II diabetics
Read More
Enrollment completed in Maxim's malginant melanoma phase III trial
Read More
NIH seeks licensees and/or CRADA partners for development of HCV vaccine
Read More
Novel gene delivery system available for licensing from NIH
Read More
Antiallergic/antiasthmatic agents from Kaken acting specifically on eosinophils
Read More
PKC inhibitors designed at Otsuka
Read More
New photoactive agents in development at QLT and U. of British Columbia
Read More
Adjuvants and immunoeffectors from AGP series under evaluation at Ribi
Read More
Nonpeptide GnRH antagonists claimed by Merck & Co.
Read More
Oxazolidinones from P&U with broad-spectrum antibacterial activity
Read More
NIH researchers determine 3-D structure of melatonin enzyme
Read More
Animal study supports cognition-enhancing efficacy of nefiracetam following ischemia
Read More
Clot-dissolving drug significantly improves disability outcome in phase III stroke trial
Read More
Abciximab undergoing clinical evaluation in acute ischemic stroke
Read More
Neuroprotective effects of FK-506 in rat stroke model not mediated by suppression of NO production
Read More
Status update for OPB-2045
Read More
Britannia seeks new owner to take the helm for a new era
Read More
Metabolism of potent new progestagen examined in vitro and in vivo
Read More
Byk Gulden's roflumilast in clinical trials; spotlight on PDE4 inhibitors for asthma
Read More
Picroliv now reported to possess promising antiallergic activity
Read More
